Skip to main content
Contact Us
Subscribe
E-Edition
78°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Celldex Therapeutics, Inc. - Common Stock
(NQ:
CLDX
)
23.35
+0.13 (+0.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 25, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Celldex Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Celldex Study Finds Most Patients Symptom-Free From Angioedema After One Year; Retail Bulls Stay Guarded
June 15, 2025
Celldex’s candidate targets KIT, a mast cell receptor tied to CSU inflammation, and had earlier met all key endpoints at 12 weeks.
Via
Stocktwits
Crude Oil Rises 6%; US Consumer Sentiment Surges In June
June 13, 2025
Via
Benzinga
Unusual Machines, Celldex Therapeutics, RH And Other Big Stocks Moving Higher On Friday
June 13, 2025
Via
Benzinga
Forecasting The Future: 8 Analyst Projections For Celldex Therapeutics
June 13, 2025
Via
Benzinga
Forecasting The Future: 6 Analyst Projections For Celldex Therapeutics
February 28, 2025
Via
Benzinga
Demystifying Celldex Therapeutics: Insights From 6 Analyst Reviews
January 29, 2025
Via
Benzinga
What Analysts Are Saying About Celldex Therapeutics Stock
December 20, 2024
Via
Benzinga
Analyst Expectations For Celldex Therapeutics's Future
April 28, 2025
Via
Benzinga
This Kohl's Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
April 28, 2025
Via
Benzinga
7 Analysts Have This To Say About Celldex Therapeutics
March 20, 2025
Via
Benzinga
This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
March 20, 2025
Via
Benzinga
Baidu, Informatica And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
February 18, 2025
Via
Benzinga
Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
November 20, 2024
Via
Benzinga
Analyst Expectations For Celldex Therapeutics's Future
October 28, 2024
Via
Benzinga
A Closer Look at 10 Analyst Recommendations For Celldex Therapeutics
September 25, 2024
Via
Benzinga
Jasper Therapeutics Skin Disorder Candidate Data Fails To Cheer Investors
January 08, 2025
Jasper Therapeutics reports strong briquilimab efficacy in CSU with UAS7 reductions, dose-dependent responses, and Phase 2b plans by late 2025.
Via
Benzinga
This HP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
September 27, 2024
Via
Benzinga
The Analyst Verdict: Celldex Therapeutics In The Eyes Of 7 Experts
September 09, 2024
Via
Benzinga
7 Analysts Have This To Say About Celldex Therapeutics
August 12, 2024
Via
Benzinga
CLDX Stock Earnings: Celldex Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 09, 2024
CLDX stock results show that Celldex Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
July 30, 2024
Via
Benzinga
Analyst Expectations For Celldex Therapeutics's Future
July 16, 2024
Via
Benzinga
Analyst Expectations For Celldex Therapeutics's Future
June 03, 2024
Via
Benzinga
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 30, 2024
Via
Benzinga
Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
July 30, 2024
Via
Benzinga
Unveiling 4 Analyst Insights On Celldex Therapeutics
May 07, 2024
Via
Benzinga
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
July 28, 2024
Top mid-cap stocks of the week: ASTS up 47.88%, GSHD up 39.86%, VSAT up 30.78%, VKTX up 29.86%, BEAM up 23.93%, CLDX up 19.72%
Via
Benzinga
CLDX Stock Earnings: Celldex Therapeutics Beats EPS, Misses Revenue for Q1 2024
May 06, 2024
CLDX stock results show that Celldex Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
March 01, 2024
U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.
Via
Benzinga
Topics
Stocks
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 26, 2024
Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
